WuXi Vaccines, a subsidiary of WuXi Biologics, focuses on human vaccine discovery, development and manufacture. An exciting new addition to the WuXi Biologics family, WuXi Vaccines will bring to the global vaccine industry the world-class integrated platforms and CDMO business model on which WuXi Biologics reputation is based.
In development is an integrated vaccine manufacturing facility with 240 million US Dollar investment, including drug substance manufacturing (DS), drug product manufacturing (DP), Manufacture Science and Technology Labs (MS&T) as well as Quality Control labs (QC), dedicated to manufacturing our partner’s vaccine products for the global market. It is expected to be operational in 2022. It will bring 200 additional new jobs to Dundalk town over five years.
Invest $240 million
Creation of 200 highly-skilled jobs
The WuXi Biologics facility will be located on the IDA Ireland Dundalk Science and Technology Park just off the M1 motorway at Junction 17, where planning permission for a biotechnology campus has been in place since 2008.
For additional information about the M1 Corridor you can visit their website: http://www.m1corridor.ie/